Pharmaceutical Studies on “Dang-Gui” in Korean Journals
10.20307/nps.2019.25.4.285
- Author:
Jongmin AHN
1
;
Mi Jeong AHN
;
Young Won CHIN
;
Jinwoong KIM
Author Information
1. College of Pharmacy and Research Institute of Pharmaceutical Sciences, Seoul National University, Seoul 08826, Republic of Korea. jwkim@snu.ac.kr
- Publication Type:Original Article
- Keywords:
Dang-Gui;
Angelica gigas;
Angelica sinensis;
Angelica acutiloba;
phytochemical;
pharmacological;
Korean journal
- MeSH:
Angelica;
Angelica sinensis;
Asia;
China;
Communication Barriers;
Herbal Medicine;
Japan;
Korea
- From:Natural Product Sciences
2019;25(4):285-292
- CountryRepublic of Korea
- Language:English
-
Abstract:
A crude drug “Dang-Gui”, belonging to the genus Angelica, has been used as a traditional herbal medicine in Asia. Various studies have investigated the chemical components and pharmacological activities of Dang-Gui worldwide. However, domestic research results published in Korean are undervalued in international academia due to language barriers. Therefore, it is necessary to summarize the domestic research findings systematically for greater accessibility. This review focuses on the results published in four Korean pharmaceutical journals between 1970 and 2018, which detail the botanical, phytochemical, and pharmacological properties of three Angelica species (A. gigas, A. sinensis, and A. acutiloba) used as “Dang-Gui” in Korea, China, and Japan.
